Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: final analysis of the GioTag study
12/04/2024 | Author: Boehringer Ingelheim
Document ID: RD-123384
12/04/2024 | Author: Boehringer Ingelheim
Document ID: RD-123384